Rituximab for ITP: a long-term fix?
Takemoto
Clifford M
CM
Pediatric Hematology, The Johns Hopkins University, Baltimore, Maryland, USA. ctakemot@jhmi.edu
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects; D002648:Child; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D000069283:Rituximab; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab